August 25, 2020
In the war on cancer and other diseases including COVID-19, old drugs approved for other conditions are being studied for new purposes. It’s a strategy that will now be tested in Alzheimer’s disease with a drug called rapamycin. A $2 million grant will enable a clinical trial in which 40 individuals with mild cognitive impairment […]
August 20, 2020
The Cancer Prevention and Research Institute of Texas awarded more than $10.3 million to the Mays Cancer Center.
August 10, 2020
A team of researchers from UT Health San Antonio and UT Southwestern have published a study in the Journal of Cancer Education showing that a new, shortened training program for health care providers may increase screenings for hepatitis C virus (HCV) across the region.
August 7, 2020
UT Health San Antonio and its clinical partner University Health System are on the front lines working to find new treatments for COVID-19.
August 3, 2020
Structures called primary cilia – which act like TV antennas for cells to detect signals – are present in fewer numbers in mice born with Fragile X syndrome, according to researchers.
July 24, 2020
The new COVID-19 and Cancer Consortium study shows that patients who were treated with the antiviral drug remdesivir fared the best.
July 24, 2020
According to a new study, SARS coronavirus 2 (SARS-CoV-2) disguises itself so it can hide inside cells without being detected by the immune system in order to replicate.
July 20, 2020
Researchers hope the study results will encourage people to exercise, reduce stress and eat a healthy diet.
Synapse-saving class of proteins discovered, opening intriguing possibilities in Alzheimer’s, schizophrenia
July 17, 2020
Researchers have discovered a new class of proteins that protect synapses from being destroyed. The discovery, published July 13 in the journal Nature Neuroscience, has implications for Alzheimer’s disease and schizophrenia.
July 16, 2020
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature.